California pay-for-delay ban upheld during appeal, rules Ninth Circuit

The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

States join antitrust suit against ‘pharma bro’ Shkreli

16 April 2020 Six state attorneys have joined a suit filed against incarcerated ‘pharma bro’ Martin Shkreli and his company Vyera Pharmaceuticals for allegedly monopolising the market for a life-saving drug.

Americas

Generics makers appeal pay-for-delay ban to Ninth Circuit

3 January 2020 A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

More on this story

Americas

States join antitrust suit against ‘pharma bro’ Shkreli

Americas

Generics makers appeal pay-for-delay ban to Ninth Circuit

3 January 2020 A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

More on this story

Americas

States join antitrust suit against ‘pharma bro’ Shkreli

Americas

Generics makers appeal pay-for-delay ban to Ninth Circuit

3 January 2020 A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.